Enhanced event-based surveillance for imported diseases during the Tokyo 2020 Olympic and Paralympic Games

Authors

  • Ayu Kasamatsu Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Masayuki Ota Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Tomoe Shimada Center for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan
  • Munehisa Fukusumi Center for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan; Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan
  • Takuya Yamagishi Center for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan
  • Anita Samuel Center for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan
  • Manami Nakashita Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Tomohiko Ukai Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Katsuki Kurosawa Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Miho Urakawa Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Kensuke Takahashi Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Keiko Tsukada Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Akane Futami Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Hideya Inoue Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Shun Omori Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Miho Kobayashi Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Hiroko Komiya Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Takahisa Shimada Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Sakiko Tabata Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan
  • Yuichiro Yahata Center for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan
  • Hajime Kamiya Center for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan
  • Fumi Yoshimatsu Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan
  • Tomimasa Sunagawa Center for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan
  • Tomoya Saito Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan

DOI:

https://doi.org/10.5365/wpsar.2021.12.4.903

Abstract

In 2021, the National Institute of Infectious Diseases, Japan, undertook enhanced event-based surveillance (EBS) for infectious diseases occurring overseas that have potential for importation (excluding coronavirus disease 2019 [COVID-19]) for the Tokyo 2020 Olympic and Paralympic Summer Games (the Games). The pre-existing EBS system was enhanced using the World Health Organization Epidemic Intelligence from Open Sources system and the BlueDot Epidemic Intelligence platform. The enhanced EBS before and during the Games did not detect any major public health event that would warrant action for the Games. However, information from multiple sources helped us identify events, characterize risk and improve confidence in risk assessment. The collaboration also reduced the surveillance workload of the host country, while ensuring the quality of surveillance, even during the COVID-19 pandemic.

Downloads

Published

22-12-2021

How to Cite

1.
Kasamatsu A, Ota M, Shimada T, Fukusumi M, Yamagishi T, Samuel A, Nakashita M, Ukai T, Kurosawa K, Urakawa M, Takahashi K, Tsukada K, Futami A, Inoue H, Omori S, Kobayashi M, Komiya H, Shimada T, Tabata S, Yahata Y, Kamiya H, Yoshimatsu F, Sunagawa T, Saito T. Enhanced event-based surveillance for imported diseases during the Tokyo 2020 Olympic and Paralympic Games. Western Pac Surveill Response J [Internet]. 2021 Dec. 22 [cited 2026 Mar. 21];12(4). Available from: https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/903

Issue

Vol. 12 No. 4 (2021): October ‒ December

Section

Surveillance Report

License

You are free to:

  • Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

When the Licensor is an intergovernmental organization, disputes will be resolved by mediation and arbitration unless otherwise agreed.

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

Most read articles by the same author(s)

1 2 3 > >>